Hyperdrug Pharmaceuticals sale to Vulcan Two Group PLC
Cattaneo Corporate Finance has advised the shareholders of Hyperdrug Pharmaceuticals on the sale of the business to AIM-listed Vulcan Two Group PLC. Vulcan Two plc (AIM:VUL) has completed the acquisition of Hyperdrug Pharmaceuticals and Cattaneo Corporate Finance is pleased to confirm its role in advising the Hyperdrug shareholders on the sale. Hyperdrug is a D2C…